SEC Form 4 · accession 0000899243-15-008462
Voyager Therapeutics, Inc. · VYGR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Period of report
Nov 16, 2015
Accepted (ET)
Nov 18, 2015 · 9:03 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001640266
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Nov 16, 2015 | C | 470,588 | — | A | 470,588 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Series B Convertible Preferred StockF1 | — | Nov 16, 2015 | C | 2,000,000 | D | — | — | Common Stock | 470,588 | 0 | D |
Explanation of responses
- F1Each share of Series B convertible preferred stock converted into shares of common stock on a 4.25-for-1 basis immediately prior to the amendment and restatement by Voyager Therapeutics, Inc. of its certificate of incorporation in connection with the closing of its initial public offering, and had no expiration date.